Letter: be careful of gastrointestinal <scp>CMV</scp> infection in adverse event from <scp>ICIs</scp> therapy in solid tumours

Letter: be careful of gastrointestinal CMV infection in adverse event from ICIs therapy in solid tumours—Authors' reply

Published:2023-03-23 Issue:8 Volume:57 Page:918-919
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:Aliment Pharmacol Ther

Author:

Dahl Emilie¹^ORCID,Abed Osama²³,Agnholt Jørgen⁴,Bjerrum Jacob¹,Dige Anders⁴,Kjeldsen Jens²³,Svane Inge⁵,Donia Marco⁵,Seidelin Jakob¹

Affiliation:

1. Department of Gastroenterology Copenhagen University Hospital Herlev Denmark

2. Department of Gastroenterology Odense University Hospital Odense Denmark

3. Research Unit of Medical Gastroenterology, Department of Clinical Research University of Southern Denmark Odense Denmark

4. Department of Hepatology and Gastroenterology Aarhus University Hospital Aarhus Denmark

5. Department of Oncology Copenhagen University Hospital Herlev Denmark

Abstract

LINKED CONTENTThis article is linked to Dahl et al papers. To view these articles, visit https://doi.org/10.1111/apt.17201 and https://doi.org/10.1111/apt.17416

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/apt.17431

Reference6 articles.

1. Letter: be careful of gastrointestinal CMV infection in adverse events from ICIs therapy in solid tumours

2. Cytomegalovirus Load in Inflamed Intestinal Tissue Is Predictive of Resistance to Immunosuppressive Therapy in Ulcerative Colitis

3. Cytomegalovirus reactivation in patients with refractory checkpoint inhibitor-induced colitis

4. Cytomegalovirus in Steroid-Refractory Immune Checkpoint Inhibition–Related Colitis